Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
J Crohns Colitis. 2023 Jan 27;17(1):83-91. doi: 10.1093/ecco-jcc/jjac108.
J Crohns Colitis. 2023.
PMID: 35913456
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I.
Bermejo F, et al. Among authors: orts b.
Inflamm Bowel Dis. 2022 Jan 5;28(1):41-47. doi: 10.1093/ibd/izab015.
Inflamm Bowel Dis. 2022.
PMID: 33528018
Item in Clipboard
Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I.
Bermejo F, et al. Among authors: orts b.
Inflamm Bowel Dis. 2022 Jan 5;28(1):150. doi: 10.1093/ibd/izab242.
Inflamm Bowel Dis. 2022.
PMID: 34636902
No abstract available.
Item in Clipboard
Hypophosphatemic osteomalacia, a side effect of iron carboxymaltose administration.
Madero Velázquez L, Muñoz Pérez R, Rodríguez A, Bernal L, Orts B, Sempere L, Gutiérrez Casbas A.
Madero Velázquez L, et al. Among authors: orts b.
Rev Esp Enferm Dig. 2022 Jun;114(6):358. doi: 10.17235/reed.2022.8621/2022.
Rev Esp Enferm Dig. 2022.
PMID: 35105150
Free article.
Item in Clipboard
Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn's Disease.
Orts B, Gutierrez A, Madero L, Sempere L, Frances R, Zapater P.
Orts B, et al.
Front Pharmacol. 2022 Jan 3;12:795272. doi: 10.3389/fphar.2021.795272. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35046819
Free PMC article.
Item in Clipboard
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease.
Martin-Cardona A, Horta D, Florez-Diez P, Vela M, Mesonero F, Ramos Belinchón C, García MJ, Masnou H, de la Peña-Negro L, Suarez Ferrer C, Casanova MJ, Durán MO, Peña E, Calvet X, Fernández-Prada SJ, González-Muñoza C, Piqueras M, Rodríguez-Lago I, Sainz E, Bas-Cutrina F, Mancediño Marcos N, Ojeda A, Orts B, Sicilia B, García AC, Domènech E, Esteve M; ENEIDA registry of GETECCU.
Martin-Cardona A, et al. Among authors: orts b.
Dig Liver Dis. 2024 Mar;56(3):468-476. doi: 10.1016/j.dld.2023.09.004. Epub 2023 Sep 26.
Dig Liver Dis. 2024.
PMID: 37770282
Item in Clipboard
Cite
Cite